Company Filing History:
Years Active: 2024
Title: Huibo Xu - Innovator in Cardiovascular Drug Development
Introduction
Huibo Xu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the development of drugs aimed at preventing and treating cardiovascular and cerebrovascular diseases. His innovative approach combines traditional herbal medicine with modern pharmacology.
Latest Patents
Huibo Xu holds a patent for the use of a combination or composition of Radix et Rhizoma Notoginseng and aspirin. This patent describes an application of this combination in the preparation of a drug for preventing and treating cardiovascular and cerebrovascular diseases. The specific dosage ranges for Radix et Rhizoma Notoginseng are between 25-500 mg/d, while the dosage for aspirin ranges from 20-700 mg/d. The combination is noted for its synergistic effect, which helps reduce gastric mucosal damage typically caused by aspirin.
Career Highlights
Huibo Xu is affiliated with the Chinese Academy of Medical Sciences, where he conducts research and development in the field of medical sciences. His work has been instrumental in bridging the gap between traditional herbal remedies and contemporary medical practices.
Collaborations
Some of Huibo Xu's notable coworkers include Xiaobo Sun and Xiangbao Meng. Their collaborative efforts contribute to the advancement of research in cardiovascular health and drug development.
Conclusion
Huibo Xu's innovative work in combining herbal medicine with modern pharmacology showcases his commitment to improving healthcare outcomes. His contributions are paving the way for new treatments in cardiovascular medicine.